This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Under $5 Making Big Moves

Chelsea Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Chelsea Therapeutics (CHTP) is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. This stock is trading up 63% at $3.94 in recent trading.

Today's Range: $3.60-$4.03

52-Week Range: $2.18-$6.06

Volume: 14.3 million

Three-Month Average Volume: 1.2 million

>>6 Drug Stocks Unworthy of a Biotech Bull Market

Shares of CHTP are soaring huge today after a committee of independent experts recommended the approval of its hypotension drug in the U.S. The FDA panel voted 7 to 4 in favor of the drug's approval on Thursday. This move will now be taken into consideration by the FDA, which is expected to vote on the drug by March 28.

From a technical perspective, CHTP is gapping up huge today on monster volume.

Market players should continue to look for long-biased trades in CHTP as long as the stock remains above $3.83 to $3.60. That $3.83 level is a near-term breakout level, and that $3.60 level is today's low price. If CHTP can continue to trend above those key technical levels with strong volume, then this stock has a great chance to tag $4.60 (its 200-day moving average) to $4.63 (its 50-day), or possibly even higher.

Keep in mind that CHTP traded as high as $5.74 back in early December.

2 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,039.21 -32.01 -0.19%
S&P 500 1,970.11 -7.69 -0.39%
NASDAQ 4,490.5880 -15.2640 -0.34%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs